Cita APA

Pennesi, E., Ammerlaan, A. C. J., Jiang, Y., van der Velden, V., Beverloo, B., Brivio, E., & Diaz de Heredia, C. (2024). Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22+ acute lymphoblastic leukemia: Results of the phase IB ITCC-059 trial.

Citación estilo Chicago

Pennesi, Edoardo, Anneke C. J. Ammerlaan, Yilin Jiang, Vincent van der Velden, Berna Beverloo, Erica Brivio, y Cristina Diaz de Heredia. Inotuzumab Ozogamicin Combined With Chemotherapy in Pediatric B-cell Precursor CD22+ Acute Lymphoblastic Leukemia: Results of the Phase IB ITCC-059 Trial. 2024.

Cita MLA

Pennesi, Edoardo, et al. Inotuzumab Ozogamicin Combined With Chemotherapy in Pediatric B-cell Precursor CD22+ Acute Lymphoblastic Leukemia: Results of the Phase IB ITCC-059 Trial. 2024.